Value Bridge — BOZEMAN DEACONESS HEALTH SERVICES
Current $-52M → Target $-43M (+$8.7M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-51.6M
Current EBITDA
$-42.8M
Target EBITDA
+$8.7M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.0M
Payer Mix Optimization
$4.7M
Cost to Collect Reduction
$1.6M
Clean Claim Improvement
$1.2M
Volume & Rate Growth
$7.9M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-52M to $-43M. The highest-impact lever is Volume & Rate Growth at $3.2M probability-weighted.
IC talking point: "We see $9M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $96M in equity value creation."